🇺🇸 FDA
Pipeline program

Lanthanum Polystyrene Sulphonate Powder

JBL-2019-001

Phase 2 small_molecule active

Quick answer

Lanthanum Polystyrene Sulphonate Powder for Hyperphosphatemia is a Phase 2 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Hyperphosphatemia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials